935 karma · joined June 4, 2011
I've written about the Australian clinical trial system and the reforms I think India needs to accelerate our slow and archaic framework twice recently:
1) https://www.infinitesunrise.com/p/we-must-accelerate-clinica...
2) https://economictimes.indiatimes.com/opinion/et-commentary/a...
PVX-001 is a broadly-protective COVID-19 vaccine candidate intended to protect against new variants of SARS-CoV-2 even as the virus mutates. It is built on our RNA-encoded virus-like particle (VLP) architecture to elicit a broad & potent immune response.
Our lipid nanoparticle (LNP) formulation, based on our own novel ionizable lipid PVXL-150, keeps the vaccine stable at 2-8 °C, regular refrigerator temperatures, for at least 9 months, rather than the -20 or -80 °C required by the first-generation mRNA vaccines approved for COVID-19. This will make it far easier to distribute the vaccine in developing countries.
The vaccine was largely funded by Vitalik Buterin's scientific investment fund Balvi -- in collaboration with them, we've made a commitment to making this vaccine open-source. Once the Phase I trial of PVX-001 concludes, we will open-source the design and manufacturing information needed for others to produce and build on it, and we will not enforce our intellectual property rights against anyone who uses it to make vaccines against any betacoronavirus -- the viral genus that includes SARS-CoV-2, SARS-CoV, and MERS-CoV.
We are doing this because SARS-CoV-2 and its close cousins remain a substantial pandemic risk. In just the past few decades, they have caused one major epidemic (SARS), one close call (MERS), and one global pandemic that killed millions. The designs developed after the original SARS outbreak gave the first generation of COVID-19 vaccines a crucial head start in 2020. We want humanity to have an even better head start next time: a broadly-protective, refrigerator-stable vaccine that any scientist, vaccine producer, or member of the public, located anywhere, can improve, adapt to their needs, and manufacture without having to worry about IP.
Pashi is building the operating system for manufacturing. We already work with some of the largest manufacturers in the world, and our software is being brought to bear against some of the thorniest problems that plague the most mission-critical high-volume production processes ever constructed.
We're currently a very small, very technical team spread across India, Europe, and the US, and we're looking for folks with strong backgrounds in programming languages and compilers to help us build better programming abstractions for physical processes.
Email soham@pashi.com with a paragraph-length description of any relevant experience if you're interested.
Happy to answer any questions about the stuff we talked about, and would appreciate any feedback you might have.
FYI, in addition to the audio, there's a complete transcript available on the page as well.
If you're interested in how India's history informs our politics, economy, and foreign relations today, take a look at Today in Indian History, a newsletter which my brother and I recently launched. Four times a week, we lay out the context and consequences of an event in India's past that happened on that date. Link below:
https://honestyisbest.com/today-in-indian-history/
I also launched a podcast about Computer Science research called Segfault.
What's the point of this? Well, Computer Science is composed of many different areas of research -- operating systems, algorithms, and cryptography, for example -- each with their own problems of interest, publications of record, idioms of communication, and styles of thought. What people doing research in these areas actually do, and how that interacts with what people in other areas do, is not usually apparent to folks who haven't spent a lot of time in academia or are just starting out.
Segfault intends to serve as a map of the field, with each episode featuring discussions about the core motivations, ideas, and methods of one particular area, with a mix of academics ranging from first year graduate students to long tenured professors as guests.
If you find the time to listen to it or read the transcript, I'd love to get your feedback.